Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.
Diseases involving the FALLOPIAN TUBES including neoplasms (FALLOPIAN TUBE NEOPLASMS); SALPINGITIS; tubo-ovarian abscess; and blockage.
Methods for assessing the patency of the fallopian tubes.
The most common (>96%) type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the FALLOPIAN TUBE, usually in the ampullary region where FERTILIZATION takes place.
Radiography of the uterus and fallopian tubes after the injection of a contrast medium.
Inflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy (PREGNANCY, ECTOPIC)
Tumors or cancer of the PERITONEUM.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
A potentially life-threatening condition in which EMBRYO IMPLANTATION occurs outside the cavity of the UTERUS. Most ectopic pregnancies (>96%) occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity (PREGNANCY, ABDOMINAL).
Procedures that render the female sterile by interrupting the flow in the FALLOPIAN TUBE. These procedures generally are surgical, and may also use chemicals or physical means.
An abnormal twisting or rotation of a bodily part or member on its axis.
Excision of one or both of the FALLOPIAN TUBES.
Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
Diminished or absent ability of a female to achieve conception.
A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)
A growth from a pollen grain down into the flower style which allows two sperm to pass, one to the ovum within the ovule, and the other to the central cell of the ovule to produce endosperm of SEEDS.
Tumors or cancer of the pelvic region.
The female reproductive organs. The external organs include the VULVA; BARTHOLIN'S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES.
Populations of thin, motile processes found covering the surface of ciliates (CILIOPHORA) or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. (King & Stansfield, A Dictionary of Genetics, 4th ed)
Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Surgery performed on the urinary tract or its organs and on the male or female genitalia.
The protrusion of an organ or part of an organ into a natural or artificial orifice.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
A tube of ectodermal tissue in an embryo that will give rise to the CENTRAL NERVOUS SYSTEM, including the SPINAL CORD and the BRAIN. Lumen within the neural tube is called neural canal which gives rise to the central canal of the spinal cord and the ventricles of the brain. For malformation of the neural tube, see NEURAL TUBE DEFECTS.

Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting. (1/167)

Dexamethasone (20 mg) or its equivalent in combination with 5-HT3 antagonists appears to be the gold-standard dose for antiemetic prophylaxis. Additional to concerns about the use of corticosteroids with respect to enhanced tumour growth or impaired killing of the tumour cells, there is evidence that high-dosage dexamethasone impairs the control of delayed nausea and emesis, whereas lower doses appear more beneficial. To come closer to the most adequate dose, we started a prospective, single-blind, randomized trial investigating additional dosage of 8 or 20 mg dexamethasone to tropisetron (Navoban), a 5-HT3 receptor antagonist, in cis-platinum-containing chemotherapy. After an interim analysis of 121 courses of chemotherapy in 69 patients, we have been unable to detect major differences between both treatment alternatives. High-dose dexamethasone (20 mg) had no advantage over medium-dose dexamethasone with respect to objective and subjective parameters of acute and delayed nausea and vomiting. In relation to concerns about the use of corticosteroids in non-haematological cancer chemotherapy, we suggest that 8 mg or its equivalent should be used in combination with 5-HT3 antagonists until further research proves otherwise.  (+info)

Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study. (2/167)

Twenty cases of primary Fallopian tube endometrioid carcinoma (PFTEC) are presented in the paper. This accounts for 42.5% of all histologic forms of primary Fallopian tube carcinoma (PFTC) found in our Department. The youngest patient was 38, and the oldest 68 years (mean: 56 years). Seven patients were nulliparas. Only two cases were bilateral. According to FIGO staging, 13 cases were evaluated as stage I, 4 as II, and 3 as stage III. Due to the histologic grading, 8 tumors were classified as well, 7 as moderately, and 5 as poorly differentiated. In the time of preparation of the manuscript, 12 women were still alive, 2 of them with recurrent disease. The follow-up of patients without recurrence ranged from 4 to 120 months (median: 63). Eight patients had died (survival time: from 4 to 65 months; median: 26). Metastases were found in 8 patients, especially to ovaries. In 14/20 cases of PFTEC various forms of tubal wall invasion were observed. Blood or lymphatic vessels involvement was found in 9 patients. Six of them had died and one is alive with the symptoms of disease. Immunohistochemical detection of the mutant form of p53 protein and oncogene product, c-erbB-2, was studied in 17 cases. Nine patients exhibited simultaneous p53 protein accumulation and c-erbB-2 expression. 2/9 of these patients are alive with recurrent tumors and 4/9 died. Endometrioid carcinoma of the Fallopian tube can be characterized by a tendency to superficial invasion of tubal wall and in a half of the cases by invasion of vessels. The majority of these tumors were diagnosed at an early stage tumors.  (+info)

Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity. (3/167)

The tumor-associated glycoprotein 72 (TAG-72) antigen is present on a high percentage of tumor types including ovarian carcinomas. Antibody B72.3 is a murine monoclonal recognizing the surface domain of the TAG-72 antigen and has been widely used in human clinical trials. After our initial encouraging studies (M. G. Rosenblum et al., J. Natl. Cancer Inst., 83: 1629-1636, 1991) of tissue disposition, metabolism, and pharmacokinetics in 9 patients with ovarian cancer, we designed an escalating dose, multi-arm Phase I study of 90Y-labeled B72.3 i.p. administration. In the first arm of the study, patients (3 pts/dose level) received an i.p. infusion of either 2 or 10 mg of B72.3 labeled with either 1, 10, 15, or 25 mCi of 90Y. Pharmacokinetic studies demonstrated that concentrations of 90Y-labeled B72.3 persist in peritoneal fluid with half-lives >24 h after i.p. administration. In addition, 90Y-labeled B72.3 was absorbed rapidly into the plasma with peak levels achieved within 48 h, and levels declined slowly thereafter. Cumulative urinary excretion of the 90Y label was 10-20% of the administered dose which suggests significant whole-body retention of the radiolabel. Biopsy specimens of bone and marrow obtained at 72 h after administration demonstrated significant content of the label in bone (0.015% of the dose/g) with relatively little in marrow (0.005% of the dose/g). The maximal tolerated dose was determined to be 10 mCi because of hematological toxicity and platelet suppression. This typically occurred on the 29th day after administration and was thought to be a consequence of the irradiation of the marrow from the bony deposition of the radiolabel. In an effort to suppress the bone uptake of 90Y, patients were treated with a continuous i.v. infusion of EDTA (25 mg/kg/12 h x 6) infused immediately before i.p. administration of the radiolabeled antibody. Patients (3 pts/dose level) were treated with doses of 10, 15, 20, 25, 30, 35, 40, or 45 mCi of 90Y-labeled B72.3 for a total of 38 patients. EDTA administration resulted in significant myeloprotection, which allowed escalation to the maximal tolerated dose of 40 mCi. Dose-limiting toxicity was thrombocytopenia and neutropenia. Studies of plasma and peritoneal fluid pharmacokinetics demonstrate no changes compared with patients without EDTA pretreatment. Cumulative urinary excretion of the radiolabel was not increased in patients pretreated with EDTA compared with the untreated group. However, analysis of biopsy specimens of bone and marrow demonstrated that bone and marrow content of the 90Y label was 15-fold lower (<0.001% injected dose/g) than a companion group without EDTA. Four responses were noted in patients who received 15-30 mCi of 90Y-labeled B72.3 with response durations of 1-12 months. These results demonstrate the myeloprotective ability of EDTA, which allows safe i.p. administration of higher doses of 90Y-labeled B72.3 and, therefore, clearly warrant an expanded Phase II trial in patients with minimal residual disease after standard chemotherapy or for the palliation of refractory ascites.  (+info)

A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer. (4/167)

The National Health Service Central Register (NHSCR) and direct follow-up were used to document ovarian and fallopian tube cancers in 22000 women from 1986 to 1993. Direct follow-up identified 47/49 cases (96%) and the NHSCR 38/49 (78%). NHSCR ascertainment was incomplete and direct follow-up provided additional information. These findings have implications for interpretation of national cancer statistics and for use of the NHSCR in research trials.  (+info)

Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. (5/167)

Carcinosarcomas of the uterus, ovaries, and fallopian tubes are highly aggressive neoplasms with incompletely understood histogenesis. Although recent immunohistochemical, cell culture, and molecular genetic studies all favor these cancers to be monoclonal in origin, the extent of intratumoral genetic heterogeneity in these tumors with divergent histology has not been reported previously. For this study, we microdissected a total of 172 carcinomatous or sarcomatous foci from 17 gynecological carcinosarcomas and analyzed allelic status with 41 microsatellite markers on chromosomal arms 1p, 1q, 3p, 4q, 5q, 6q, 8p, 9p, 10q, 11p, 11q, 13q, 16q, 17p, 17q, 18q, and 22q. With the exception of a single case with microsatellite instability, we found shared allelic losses and retentions among multiple individually dissected foci of each case, strongly supportive of the concept of a monoclonal origin for these neoplasms. In eight of these cases, we also found heterogeneous patterns of allelic loss at limited numbers of chromosomal loci in either the carcinomatous or sarcomatous components of the neoplasms. These heterogeneous patterns of allelic losses were consistent with either genetic progression or genetic diversion occurring during the clonal evolution of these neoplasms. In two cases, we found the specific patterns of genetic progression to be consistent with sarcomatous components of the neoplasms arising from carcinomatous components. We conclude that most of the gynecological carcinosarcomas have a monoclonal origin, and that genetic progression and diversion parallel the development of divergent phenotypes in these tumors. Because phenotypically divergent areas of the tumors share numerous genetic alterations, this divergence most likely occurs relatively late in the evolution of these tumors.  (+info)

Primary carcinoma of the fallopian tube coexisting with benign cystic teratoma of the ovary. (6/167)

Primary carcinoma of the fallopian tube is a rare malignancy of the female genital tract and infrequently diagnosed before an operation. The majority of patients have extensive disease at the time of diagnosis. We have experienced incidentally a case of a carcinoma of the fallopian tube coexisting with a benign cystic teratoma of the ovary in a 25-year-old woman. We report this case with a brief review of literatures.  (+info)

Preoperative diagnosis of the primary fallopian tube carcinoma by three-dimensional static and power Doppler sonography. (7/167)

OBJECTIVE: To investigate whether three-dimensional static and power Doppler ultrasound improves the diagnosis of primary Fallopian tube carcinoma. METHODS: During a 2-year period five cases of primary Fallopian tube carcinoma were selected from a cohort of 520 patients with a previous scan suggestive of an adnexal tumor. RESULTS: Tubal malignancy occurred in patients between 49 and 64 years, with presenting symptoms such as pain, vaginal bleeding and leukorrhea. CA 125 was elevated in three cases of tubal carcinoma with stages II and III, while in two patients with stage I, CA 125 was within the normal limits. Two-dimensional ultrasound demonstrated sausage shaped cystic masses with papillary projections in two patients and a complex adnexal mass in one patient. Three-dimensional ultrasound revealed sausage shaped cystic and/or complex masses with papillary projections in all five cases of tubal malignancy. In one patient preoperative 3-D ultrasound correctly predicted bilateral tumors, while 2-D transvaginal sonography found only unilateral changes. Additional 3-D power Doppler examination depicted vascular geometry typical for malignant tumor vessels such as arteriovenous shunts, microaneurysms, tumoral lakes, blind ends and dichotomous branching in each of the cases with Fallopian tube carcinoma. CONCLUSIONS: Three-dimensional ultrasound allows precise depiction of tubal wall irregularities such as papillary protrusions and pseudosepta. Improved understanding of anatomical relationships may aid in distinguishing ovarian from tubal pathology. Multiple sections of the tubal sausage like structures enable determination of local tumor spread and capsule infiltration. Study of the vascular architecture in cases of Fallopian tube malignancy is further enhanced using 3-D power Doppler imaging.  (+info)

Docetaxel for patients with paclitaxel-resistant Mullerian carcinoma. (8/167)

PURPOSE: To determine the efficacy and toxicity of docetaxel in patients with mullerian carcinoma resistant to paclitaxel. PATIENTS AND METHODS: Thirty-two patients with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who failed paclitaxel-based chemotherapy received either 100 or 75 mg/m(2) of docetaxel every 3 weeks. Resistance to paclitaxel was defined as either progression of disease during treatment, failure to achieve regression of disease after at least four courses, or rapid recurrence (within 6 months) after completion of therapy. RESULTS: Eighteen patients were treated on a formal protocol and fourteen with the commercially available docetaxel. Thirty were assessable for response. Toxicities were thoroughly evaluated in the 18 patients on protocol. Twenty-seven patients (85%) had epithelial ovarian cancer. The overall response rate was 23% (one complete and six partial responses), with a median survival time of 44 weeks (9.5 months). Nine patients had stable disease and 14 progressive disease. Among 19 patients who progressed during prior paclitaxel treatment, two (11%) responded to docetaxel, compared with five (45%) of 11 patients in other paclitaxel-resistance categories. The responders had a median taxane-free interval (ie, the time between the last paclitaxel and first docetaxel treatment) of 73 weeks, compared with 19 weeks for the nonresponder group. Toxic effects were as expected. CONCLUSION: Docetaxel is an active chemotherapeutic agent in patients with mullerian carcinoma previously treated with paclitaxel-based chemotherapy, especially in the patients who had a long taxane-free interval after a previous short response to paclitaxel.  (+info)

Fallopian tube neoplasms are abnormal growths that occur in the epithelial lining of the fallopian tubes, which are a pair of narrow tubes that transport eggs from the ovaries to the uterus during ovulation. These neoplasms can be benign (non-cancerous) or malignant (cancerous).

Benign neoplasms of the fallopian tube include adenomas, papillomas, and leiomyomas. They are usually asymptomatic but can cause symptoms such as pelvic pain, abnormal vaginal bleeding, and infertility. Treatment typically involves surgical removal of the neoplasm.

Malignant neoplasms of the fallopian tube are rare and include primary fallopian tube carcinoma and metastatic tumors that have spread to the fallopian tubes from other organs. Primary fallopian tube carcinoma is a highly aggressive cancer that can cause symptoms such as abnormal vaginal bleeding, pelvic pain, and watery discharge. Treatment typically involves surgical removal of the affected tube, followed by chemotherapy and radiation therapy.

Overall, Fallopian tube neoplasms are uncommon but can have serious consequences if left untreated. Regular gynecological exams and screenings can help detect these neoplasms early and improve treatment outcomes.

The Fallopian tubes, also known as uterine tubes or oviducts, are a pair of slender tubular structures in the female reproductive system. They play a crucial role in human reproduction by providing a passageway for the egg (ovum) from the ovary to the uterus (womb).

Each Fallopian tube is typically around 7.6 to 10 centimeters long and consists of four parts: the interstitial part, the isthmus, the ampulla, and the infundibulum. The fimbriated end of the infundibulum, which resembles a fringe or frill, surrounds and captures the released egg from the ovary during ovulation.

Fertilization usually occurs in the ampulla when sperm meets the egg after sexual intercourse. Once fertilized, the zygote (fertilized egg) travels through the Fallopian tube toward the uterus for implantation and further development. The cilia lining the inner surface of the Fallopian tubes help propel the egg and the zygote along their journey.

In some cases, abnormalities or blockages in the Fallopian tubes can lead to infertility or ectopic pregnancies, which are pregnancies that develop outside the uterus, typically within the Fallopian tube itself.

Fallopian tube diseases refer to conditions that affect the function or structure of the Fallopian tubes, which are a pair of narrow tubes that transport the egg from the ovaries to the uterus during ovulation and provide a pathway for sperm to reach the egg for fertilization. Some common Fallopian tube diseases include:

1. Salpingitis: This is an inflammation of the Fallopian tubes, usually caused by an infection. The infection can be bacterial, viral, or fungal in origin and can lead to scarring, blockage, or damage to the Fallopian tubes.
2. Hydrosalpinx: This is a condition where one or both of the Fallopian tubes become filled with fluid, leading to swelling and distension of the tube. The cause of hydrosalpinx can be infection, endometriosis, or previous surgery.
3. Endometriosis: This is a condition where the tissue that lines the inside of the uterus grows outside of it, including on the Fallopian tubes. This can lead to scarring, adhesions, and blockage of the tubes.
4. Ectopic pregnancy: This is a pregnancy that develops outside of the uterus, usually in the Fallopian tube. An ectopic pregnancy can cause the Fallopian tube to rupture, leading to severe bleeding and potentially life-threatening complications.
5. Tubal ligation: This is a surgical procedure that involves blocking or cutting the Fallopian tubes to prevent pregnancy. In some cases, tubal ligation can lead to complications such as ectopic pregnancy or tubal sterilization syndrome, which is a condition where the fallopian tubes reconnect and allow for pregnancy to occur.

These conditions can cause infertility, chronic pain, and other health problems, and may require medical or surgical treatment.

Fallopian tube patency tests are medical procedures used to determine whether the fallopian tubes, which are the pair of narrow tubes that connect the ovaries to the uterus in females, are open and functioning properly. The tests typically involve introducing a dye or gas into the uterus and observing whether it flows freely through the fallopian tubes and spills out of the ends.

There are several types of Fallopian tube patency tests, including:

1. Hysterosalpingogram (HSG): This is a radiologic procedure that involves injecting a dye into the uterus through the cervix while taking X-rays to observe the flow of the dye through the fallopian tubes.
2. Sonohysterography: This is an ultrasound procedure that involves injecting a sterile saline solution into the uterus through the cervix and observing the flow of the fluid through the fallopian tubes using ultrasound imaging.
3. Falloposcopy: This is a minimally invasive procedure that involves inserting a thin, flexible tube with a camera into the uterus and fallopian tubes to directly visualize their patency and any abnormalities.
4. Hysterosalpingo-contrast sonography (HyCoSy): This is an ultrasound procedure that involves injecting a contrast medium into the uterus through the cervix while observing the flow of the contrast through the fallopian tubes using ultrasound imaging.

These tests are often performed as part of an infertility evaluation to determine whether blocked or damaged fallopian tubes may be contributing to difficulty conceiving.

Tubal pregnancy, also known as an ectopic pregnancy, is a type of pregnancy that occurs outside the uterus, usually in the fallopian tube. The fertilized egg implants and starts to develop in the tube instead of the uterine lining. This condition is not viable and can be life-threatening if not treated promptly.

The symptoms of a tubal pregnancy may include abdominal pain, vaginal bleeding, shoulder pain, dizziness or fainting, and pelvic discomfort or tenderness. If you suspect that you have a tubal pregnancy, it is important to seek medical attention immediately. Treatment options for tubal pregnancies include medication or surgery to remove the embryo and repair or remove the affected fallopian tube.

Hysterosalpingography (HSG) is a medical diagnostic procedure that involves the use of fluoroscopy and a contrast medium to examine the internal structure of the uterus and fallopian tubes. It is primarily used to diagnose abnormalities related to the shape and size of the uterus, endometrial lining, and fallopian tubes, including blockages or scarring that may affect fertility.

During the procedure, a thin catheter is inserted through the cervix into the uterus, and a contrast medium is injected. The radiologist then takes X-ray images as the contrast fills the uterine cavity and flows through the fallopian tubes. This allows for the visualization of any abnormalities such as blockages, scarring, or structural issues that may be impacting fertility or menstrual function.

HSG is typically performed in a radiology department or outpatient clinic by a trained radiologist or gynecologist. It is usually recommended for women who are experiencing infertility, recurrent miscarriages, or abnormal menstrual bleeding, and may be used as part of an evaluation prior to fertility treatments such as in vitro fertilization (IVF).

Salpingitis is a medical term that refers to the inflammation of the fallopian tubes, which are the pair of narrow tubes that transport the egg from the ovaries to the uterus during ovulation. This condition can occur due to various reasons, including bacterial infections (such as chlamydia or gonorrhea), pelvic inflammatory disease, or complications following surgical procedures.

Acute salpingitis is characterized by symptoms like lower abdominal pain, fever, vaginal discharge, and irregular menstrual bleeding. Chronic salpingitis may not present any noticeable symptoms, but it can lead to complications such as infertility, ectopic pregnancy, or fallopian tube damage if left untreated. Treatment typically involves antibiotics to eliminate the infection and, in severe cases, surgery to remove or repair damaged tissues.

Peritoneal neoplasms refer to tumors or cancerous growths that develop in the peritoneum, which is the thin, transparent membrane that lines the inner wall of the abdomen and covers the organs within it. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Malignant peritoneal neoplasms are often associated with advanced stages of gastrointestinal, ovarian, or uterine cancers and can spread (metastasize) to other parts of the abdomen.

Peritoneal neoplasms can cause various symptoms such as abdominal pain, bloating, nausea, vomiting, loss of appetite, and weight loss. Diagnosis typically involves imaging tests like CT scans or MRIs, followed by a biopsy to confirm the presence of cancerous cells. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches, depending on the type, stage, and location of the neoplasm.

Ovarian neoplasms refer to abnormal growths or tumors in the ovary, which can be benign (non-cancerous) or malignant (cancerous). These growths can originate from various cell types within the ovary, including epithelial cells, germ cells, and stromal cells. Ovarian neoplasms are often classified based on their cell type of origin, histological features, and potential for invasive or metastatic behavior.

Epithelial ovarian neoplasms are the most common type and can be further categorized into several subtypes, such as serous, mucinous, endometrioid, clear cell, and Brenner tumors. Some of these epithelial tumors have a higher risk of becoming malignant and spreading to other parts of the body.

Germ cell ovarian neoplasms arise from the cells that give rise to eggs (oocytes) and can include teratomas, dysgerminomas, yolk sac tumors, and embryonal carcinomas. Stromal ovarian neoplasms develop from the connective tissue cells supporting the ovary and can include granulosa cell tumors, thecomas, and fibromas.

It is essential to diagnose and treat ovarian neoplasms promptly, as some malignant forms can be aggressive and potentially life-threatening if not managed appropriately. Regular gynecological exams, imaging studies, and tumor marker tests are often used for early detection and monitoring of ovarian neoplasms. Treatment options may include surgery, chemotherapy, or radiation therapy, depending on the type, stage, and patient's overall health condition.

Cystadenocarcinoma, serous is a type of cystic tumor that arises from the lining of the abdominal or pelvic cavity (the peritoneum). It is called "serous" because the tumor cells produce a thin, watery fluid similar to serum.

Cystadenocarcinoma is a malignant (cancerous) tumor that can invade surrounding tissues and spread (metastasize) to other parts of the body. It typically affects women over the age of 50 and can cause symptoms such as abdominal pain, bloating, and changes in bowel or bladder habits.

Serous cystadenocarcinoma is a subtype of ovarian cancer that arises from the surface of the ovary. It can also occur in other organs, including the fallopian tubes, peritoneum, and endometrium. This type of tumor tends to grow slowly but can spread widely throughout the abdominal cavity, making it difficult to treat.

Treatment for serous cystadenocarcinoma typically involves surgery to remove the tumor and any affected tissues, followed by chemotherapy to kill any remaining cancer cells. The prognosis for this type of cancer depends on several factors, including the stage of the disease at diagnosis, the patient's age and overall health, and the response to treatment.

Ectopic pregnancy is a type of abnormal pregnancy that occurs outside the uterine cavity. The most common site for an ectopic pregnancy is the fallopian tube, accounting for about 95% of cases. This condition is also known as tubal pregnancy. Other less common sites include the ovary, cervix, and abdominal cavity.

In a normal pregnancy, the fertilized egg travels down the fallopian tube and implants itself in the lining of the uterus. However, in an ectopic pregnancy, the fertilized egg implants and starts to develop somewhere other than the uterus. The growing embryo cannot survive outside the uterus, and if left untreated, an ectopic pregnancy can cause life-threatening bleeding due to the rupture of the fallopian tube or other organs.

Symptoms of ectopic pregnancy may include abdominal pain, vaginal bleeding, shoulder pain, lightheadedness, fainting, and in severe cases, shock. Diagnosis is usually made through a combination of medical history, physical examination, ultrasound, and blood tests to measure the levels of human chorionic gonadotropin (hCG), a hormone produced during pregnancy.

Treatment for ectopic pregnancy depends on several factors, including the location, size, and growth rate of the ectopic mass, as well as the patient's overall health and desire for future pregnancies. Treatment options may include medication to stop the growth of the embryo or surgery to remove the ectopic tissue. In some cases, both methods may be used together. Early diagnosis and treatment can help prevent serious complications and improve the chances of preserving fertility in future pregnancies.

Tubal sterilization, also known as female sterilization or tubal ligation, is a permanent form of birth control for women. It involves blocking, sealing, or removing the fallopian tubes, which prevents the sperm from reaching and fertilizing the egg. This procedure can be performed surgically through various methods such as cutting and tying the tubes, using clips or rings to block them, or removing a portion of the tube (known as a partial salpingectomy). Tubal sterilization is considered a highly effective form of contraception with a low failure rate. However, it does not protect against sexually transmitted infections and should be combined with condom use for that purpose. It's important to note that tubal sterilization is a permanent procedure and cannot be easily reversed.

A "torsion abnormality" is not a standard medical term, but I believe you are asking about torsional deformities or abnormalities related to torsion. Torsion refers to a twisting force or movement that can cause structures to rotate around their long axis. In the context of medical definitions:

Torsional abnormality could refer to a congenital or acquired condition where anatomical structures, such as blood vessels, muscles, tendons, or bones, are twisted or rotated in an abnormal way. This can lead to various complications depending on the structure involved and the degree of torsion.

For instance, in congenital torsional deformities of long bones (like tibia or femur), the rotation of the bone axis can cause issues with gait, posture, and joint function. In some cases, this may require surgical intervention to correct the abnormality.

In the context of vascular torsion abnormalities, such as mesenteric torsion, it could lead to bowel ischemia due to the twisting of blood vessels that supply the intestines. This can be a surgical emergency and requires immediate intervention to restore blood flow and prevent further damage.

It's essential to consult with a medical professional for a precise diagnosis and treatment options if you or someone else experiences symptoms related to torsional abnormalities.

Salpingectomy is a surgical procedure in which one or both of the fallopian tubes are removed. These tubes are slender structures that connect the ovaries to the uterus, through which the egg travels from the ovary to the uterus during ovulation. Salpingectomy can be performed for various reasons such as ectopic pregnancy, salpingitis (inflammation of the fallopian tubes), hydrosalpinx (fluid-filled tube), or as a preventative measure in women with increased risk of ovarian cancer. The procedure can be carried out through laparoscopy, hysteroscopy, or laparotomy, depending on the patient's condition and the surgeon's preference.

Neoplasms are abnormal growths of cells or tissues that serve no purpose and can be benign (non-cancerous) or malignant (cancerous). Glandular and epithelial neoplasms refer to specific types of tumors that originate from the glandular and epithelial tissues, respectively.

Glandular neoplasms arise from the glandular tissue, which is responsible for producing and secreting substances such as hormones, enzymes, or other fluids. These neoplasms can be further classified into adenomas (benign) and adenocarcinomas (malignant).

Epithelial neoplasms, on the other hand, develop from the epithelial tissue that lines the outer surfaces of organs and the inner surfaces of cavities. These neoplasms can also be benign or malignant and are classified as papillomas (benign) and carcinomas (malignant).

It is important to note that while both glandular and epithelial neoplasms can become cancerous, not all of them do. However, if they do, the malignant versions can invade surrounding tissues and spread to other parts of the body, making them potentially life-threatening.

Female infertility is a condition characterized by the inability to conceive after 12 months or more of regular, unprotected sexual intercourse or the inability to carry a pregnancy to a live birth. The causes of female infertility can be multifactorial and may include issues with ovulation, damage to the fallopian tubes or uterus, endometriosis, hormonal imbalances, age-related factors, and other medical conditions.

Some common causes of female infertility include:

1. Ovulation disorders: Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, premature ovarian failure, and hyperprolactinemia can affect ovulation and lead to infertility.
2. Damage to the fallopian tubes: Pelvic inflammatory disease, endometriosis, or previous surgeries can cause scarring and blockages in the fallopian tubes, preventing the egg and sperm from meeting.
3. Uterine abnormalities: Structural issues with the uterus, such as fibroids, polyps, or congenital defects, can interfere with implantation and pregnancy.
4. Age-related factors: As women age, their fertility declines due to a decrease in the number and quality of eggs.
5. Other medical conditions: Certain medical conditions, such as diabetes, celiac disease, and autoimmune disorders, can contribute to infertility.

In some cases, female infertility can be treated with medications, surgery, or assisted reproductive technologies (ART) like in vitro fertilization (IVF). A thorough evaluation by a healthcare professional is necessary to determine the underlying cause and develop an appropriate treatment plan.

A serous cystadenoma is a type of benign tumor that arises from the epithelial cells lining the serous glands, which are glands that produce a watery, lubricating fluid. This type of tumor typically develops in the ovary or the pancreas.

Serous cystadenomas of the ovary are usually filled with a clear, watery fluid and have multiple loculations (compartments). They can vary in size from a few millimeters to several centimeters in diameter. Although these tumors are benign, they can cause symptoms if they become large enough to press on surrounding organs or if they rupture and release their contents into the abdominal cavity.

Serous cystadenomas of the pancreas are less common than ovarian serous cystadenomas. They typically occur in the tail of the pancreas and can range in size from a few millimeters to several centimeters in diameter. These tumors are usually asymptomatic, but they can cause symptoms such as abdominal pain or discomfort if they become large enough to press on surrounding organs.

It is important to note that while serous cystadenomas are generally benign, there is a small risk that they may undergo malignant transformation and develop into a type of cancer known as a serous cystadenocarcinoma. For this reason, it is important for patients with these tumors to be followed closely by a healthcare provider and to have regular imaging studies and/or surgical excision to monitor for any changes in the tumor.

A pollen tube is a slender, tubular structure that grows out from the germinated grain of pollen and transports the male gametes (sperm cells) to the female reproductive organ in seed plants. This process is known as double fertilization, which occurs in angiosperms (flowering plants).

The pollen tube elongates through the stigma and style of the pistil, following a path towards the ovule. Once it reaches the ovule, the generative cell within the pollen tube divides to form two sperm cells. One sperm fertilizes the egg cell, forming a zygote, while the other sperm fuses with the central cell of the embryo sac, leading to the formation of endosperm - a nutritive tissue for the developing embryo.

In summary, a pollen tube is a crucial component in the reproductive process of seed plants, facilitating the transfer of male gametes to female gametes and ultimately resulting in fertilization and seed development.

Pelvic neoplasms refer to abnormal growths or tumors located in the pelvic region. These growths can be benign (non-cancerous) or malignant (cancerous). They can originate from various tissues within the pelvis, including the reproductive organs (such as ovaries, uterus, cervix, vagina, and vulva in women; and prostate, testicles, and penis in men), the urinary system (kidneys, ureters, bladder, and urethra), the gastrointestinal tract (colon, rectum, and anus), as well as the muscles, nerves, blood vessels, and other connective tissues.

Malignant pelvic neoplasms can invade surrounding tissues and spread to distant parts of the body (metastasize). The symptoms of pelvic neoplasms may vary depending on their location, size, and type but often include abdominal or pelvic pain, bloating, changes in bowel or bladder habits, unusual vaginal bleeding or discharge, and unintentional weight loss. Early detection and prompt treatment are crucial for improving the prognosis of malignant pelvic neoplasms.

Female genitalia refer to the reproductive and sexual organs located in the female pelvic region. They are primarily involved in reproduction, menstruation, and sexual activity. The external female genitalia, also known as the vulva, include the mons pubis, labia majora, labia minora, clitoris, and the external openings of the urethra and vagina. The internal female genitalia consist of the vagina, cervix, uterus, fallopian tubes, and ovaries. These structures work together to facilitate menstruation, fertilization, pregnancy, and childbirth.

Cilia are tiny, hair-like structures that protrude from the surface of many types of cells in the body. They are composed of a core bundle of microtubules surrounded by a protein matrix and are covered with a membrane. Cilia are involved in various cellular functions, including movement of fluid or mucus across the cell surface, detection of external stimuli, and regulation of signaling pathways.

There are two types of cilia: motile and non-motile. Motile cilia are able to move in a coordinated manner to propel fluids or particles across a surface, such as those found in the respiratory tract and reproductive organs. Non-motile cilia, also known as primary cilia, are present on most cells in the body and serve as sensory organelles that detect chemical and mechanical signals from the environment.

Defects in cilia structure or function can lead to a variety of diseases, collectively known as ciliopathies. These conditions can affect multiple organs and systems in the body, including the brain, kidneys, liver, and eyes. Examples of ciliopathies include polycystic kidney disease, Bardet-Biedl syndrome, and Meckel-Gruber syndrome.

Neural Tube Defects (NTDs) are a group of birth defects that affect the brain, spine, or spinal cord. They occur when the neural tube, which forms the early brain and spinal cord of the embryo, does not close properly during fetal development. This can result in various conditions such as:

1. Anencephaly: a severe defect where most of the brain and skull are missing. Infants with anencephaly are usually stillborn or die shortly after birth.
2. Spina bifida: a condition where the spine does not close properly, leaving a portion of the spinal cord and nerves exposed. This can result in various neurological problems, including paralysis, bladder and bowel dysfunction, and hydrocephalus (fluid buildup in the brain).
3. Encephalocele: a condition where the skull does not close properly, allowing the brain to protrude through an opening in the skull. This can result in various neurological problems, including developmental delays, vision and hearing impairments, and seizures.

NTDs are thought to be caused by a combination of genetic and environmental factors, such as folic acid deficiency, obesity, diabetes, and exposure to certain medications during pregnancy. Folic acid supplementation before and during early pregnancy has been shown to reduce the risk of NTDs.

Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.

Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.

Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.

There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.

Multiple primary neoplasms refer to the occurrence of more than one primary malignant tumor in an individual, where each tumor is unrelated to the other and originates from separate cells or organs. This differs from metastatic cancer, where a single malignancy spreads to multiple sites in the body. Multiple primary neoplasms can be synchronous (occurring at the same time) or metachronous (occurring at different times). The risk of developing multiple primary neoplasms increases with age and is associated with certain genetic predispositions, environmental factors, and lifestyle choices such as smoking and alcohol consumption.

Urogenital surgical procedures refer to surgeries that are performed on the urinary and genital systems. The urinary system includes the kidneys, ureters, bladder, and urethra, while the genital system includes the reproductive organs such as the ovaries, fallopian tubes, uterus, vagina, testicles, epididymis, vas deferens, prostate, and penis.

Urogenital surgical procedures can be performed for various reasons, including the treatment of diseases, injuries, or congenital abnormalities. Some examples of urogenital surgical procedures include:

1. Cystectomy: the removal of the bladder.
2. Nephrectomy: the removal of a kidney.
3. Prostatectomy: the removal of all or part of the prostate gland.
4. Hysterectomy: the removal of the uterus and sometimes the ovaries and fallopian tubes.
5. Vasectomy: a surgical procedure for male sterilization, in which the vas deferens is cut and tied.
6. Vaginoplasty: a surgical procedure to construct or repair a vagina.
7. Urethroplasty: a surgical procedure to reconstruct or repair the urethra.
8. Pyeloplasty: a surgical procedure to correct a congenital or acquired narrowing of the renal pelvis, the area where urine collects before flowing into the ureter.

These procedures can be performed using various surgical techniques, including open surgery, laparoscopic surgery, and robotic-assisted surgery. The choice of technique depends on several factors, including the patient's overall health, the location and extent of the disease or injury, and the surgeon's expertise.

A prolapse is a medical condition where an organ or tissue in the body slips from its normal position and drops down into a lower part of the body. This usually occurs when the muscles and ligaments that support the organ become weak or stretched. The most common types of prolapses include:

* Uterine prolapse: When the uterus slips down into or protrudes out of the vagina.
* Rectal prolapse: When the rectum (the lower end of the colon) slips outside the anus.
* Bladder prolapse (cystocele): When the bladder drops into the vagina.
* Small bowel prolapse (enterocele): When the small intestine bulges into the vagina.

Prolapses can cause various symptoms, such as discomfort, pain, pressure, and difficulty with urination or bowel movements. Treatment options depend on the severity of the prolapse and may include lifestyle changes, physical therapy, medication, or surgery.

Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.

Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.

Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.

Adenocarcinoma, papillary is a type of cancer that begins in the glandular cells and grows in a finger-like projection (called a papilla). This type of cancer can occur in various organs, including the lungs, pancreas, thyroid, and female reproductive system. The prognosis and treatment options for papillary adenocarcinoma depend on several factors, such as the location and stage of the tumor, as well as the patient's overall health. It is important to consult with a healthcare professional for an accurate diagnosis and personalized treatment plan.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

The Neural Tube is a structure that forms during the development of an embryo and eventually becomes the brain, spinal cord, and other parts of the nervous system. It is a narrow channel that runs along the back of the embryo, forming from the ectoderm (one of the three germ layers) and closing around the 23rd or 26th day after conception. Defects in the closure of the neural tube can lead to conditions such as spina bifida and anencephaly.

Delmore, James E. (2008). "Benign Neoplasms of the Vagina". GLOWM. doi:10.3843/GLOWM.10005. ISSN 1756-2228. Retrieved 11 March ... The fallopian tubes, also known as uterine tubes, oviducts or salpinges (SG: salpinx), are paired tubes in the human female ... Fallopian tube obstruction may be a cause of infertility or ectopic pregnancy. If a blocked fallopian tube has affected ... In other mammals the fallopian tube is called the oviduct which may also be used in reference to the fallopian tube in the ...
Primary fallopian tube cancer (PFTC), often just tubal cancer, is a malignant neoplasm that originates from the fallopian tube ... Growth limited to fallopian tubes Stage II: Growth involving one or both fallopian tubes with extension to pelvis Stage III: ... Tumor involving one or both fallopian tubes with spread outside pelvis Stage IV: Growth involving one or more fallopian tubes ... Occasionally, an early fallopian tube cancer may be detected by chance during pelvic surgery. International Federation of ...
Clinical characteristics and outcomes of pa- tients with stage I epithelial ovarian cancer compared to fallo- pian tube cancer ... Surface epithelial-stromal tumors are a class of ovarian neoplasms that may be benign or malignant. Neoplasms in this group are ... or from ectopic endometrial or Fallopian tube (tubal) tissue. Tumors of this type are also called ovarian adenocarcinoma. This ... One rare but noteworthy condition associated with mucinous ovarian neoplasms is pseudomyxoma peritonei. As primary ovarian ...
MeSH C13.371.056.390 - fallopian tube diseases MeSH C13.371.056.390.390 - fallopian tube neoplasms MeSH C13.371.056.390.890 - ... fallopian tube neoplasms MeSH C13.371.820.800.418.685 - ovarian neoplasms MeSH C13.371.820.800.418.685.265 - brenner tumor MeSH ... vaginal neoplasms MeSH C13.371.820.800.418.968 - vulvar neoplasms MeSH C13.371.820.800.820 - urologic neoplasms MeSH C13.371. ... ureteral neoplasms MeSH C13.371.820.800.820.890 - urethral neoplasms MeSH C13.371.852.150 - uterine cervical diseases MeSH ...
Hydrosalpinx, or fallopian tube dilation, can be mistaken for an ovarian cyst due to its anechoic appearance. Follow-up for ... The presence of multiloculation suggests a neoplasm, although the thin septation implies that the neoplasm is benign. For any ... The corpus luteum is the remnant of the follicle after the ovum has moved to the fallopian tubes. This normally degrades within ...
Evidence is insufficient as of 2020 to support its use in primary advanced epithelial ovarian, fallopian tube or primary ... or disseminated mucinous neoplasm of the appendix. These procedures can be 8-10 hours long and carry a significant rate of ...
"Fallopian tubes & broad ligament - Fallopian tube tumors - Adenomatoid tumor". Pathology Outlines. Archived from the original ... Benign neoplasms, Connective and soft tissue neoplasms). ... An adenomatoid tumor of the fallopian tube, low magnification, ... In the female, it has been found in the body of the uterus and the fallopian tube. Most adenomatoid tumors do not cause much ... It is the most common extratesticular neoplasm after lipoma, and accounts for 30% of these masses. On the other hand, ...
... reconstructive surgery of the fallopian tubes), full removal of ovarian cysts, and myomectomies (full removal of fibroids), ... cautery of neoplasms, and tubal ligations. When Nezhat began using his new video-laparoscopic technique of operating off the ... cauterizing of neoplasms, biopsies, and tubal ligations. This meant that other, more complicated gynecologic surgical ...
The syndrome also causes increased risk of extraintestinal cancer such as that involving breast, ovary, cervix, fallopian tubes ... A neoplasm is a tissue whose cells have lost normal differentiation. They can be either benign growths or malignant growths. ... Paris classification of colorectal neoplasms In colonoscopy, colorectal polyps can be classified by NICE (Narrow-band imaging ...
... fallopian tubes, or any of the surrounding connective tissue). Adnexal masses can be benign or cancerous, and they can be ... Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989; 74:921. Magrina JF, Espada M, Munoz R, ...
This cyst can be lined with epithelium from the cervix, uterus and fallopian tubes. An epithelial inclusion cyst is also ... "Benign Neoplasms of the Vagina , GLOWM". www.glowm.com. Retrieved 2018-03-01. Jaya Prakash, Sheela; M, Lakshmi devi; G, Sampath ...
... and the fallopian tube on the opposite side can be left behind. This is not an option when the cancer is in both ovaries. If ... Germ cell tumor (GCT) is a neoplasm derived from germ cells. Germ-cell tumors can be cancerous or benign. Germ cells normally ... of all germ cell neoplasms pelvis, particularly sacrococcygeal teratoma In females, GCTs account for 30% of ovarian tumors, but ...
Sperm cell flagella and Fallopian tube cilia are homologous structures. The testis-specific proteins that show the highest ... To improve the chances of catching cases of testicular cancer, other neoplasms, or other health issues early, regular ... these same proteins are expressed in the female in cells lining the Fallopian tube and cause the development of cilia. ... Under the tunica albuginea, the testes contain very fine-coiled tubes called seminiferous tubules. The tubules are lined with a ...
Beginning in the year 2000, the fallopian tube, specifically the fimbriated end, has emerged as an origin for many "ovarian" ... They are common neoplasms with a strong tendency to occur bilaterally, and they account for approximately a quarter of all ... which play close attention to the distal fallopian tube and have revealed early serous cancers and precancers in this region. ... A serous tumour is a neoplasm that typically has papillary to solid formations of tumor cells with crowded nuclei, and which ...
... is connected to the fallopian tubes, at the uterine horns, and the rounded part above the openings to the fallopian tubes is ... Prolapse of the uterus Carcinoma of the cervix - malignant neoplasm Carcinoma of the uterus - malignant neoplasm Fibroids - ... In females, these ducts give rise to the fallopian tubes and the uterus. In humans, the lower segments of the two ducts fuse to ... The fertilized egg is carried to the uterus along the fallopian tube. It will have divided on its journey to form a blastocyst ...
... is an abortifacient and is used to treat ectopic pregnancies, provided the fallopian tube has not ruptured. ... a study of 93 patients with incurable neoplasms". Journal of the National Medical Association. 43 (4): 211-40. PMC 2616951. ... and choriocarcinoma and other trophoblastic neoplasms. Although originally designed as a chemotherapy drug, in lower doses ...
Fallopian tube, seminal vesicle, epididymis, pancreatic islet cells and lymphoid cells. PAX8 and other transcription factors ... aka Hurthle-Cell Neoplasms). Expression of PAX8 is increased in neoplastic renal tissues, Wilms tumors, ovarian cancer and ...
Stage II: The cancer is in one or both ovaries or fallopian tubes and has spread into the pelvis. Stage III: The cancer has ... The cysts are approximately 2 cm in diameter and populated throughout the tissue which results in giving the neoplasm a ' ... Stage I: Tumor cells are localized in the ovaries or the fallopian tubes without extensive spread to other body regions. ... Fertility-preserving surgery is primarily standardized to keep the contralateral ovary and fallopian tube intact, also known as ...
... and by causing reverse contractions of parts of the female reproductive tract such as the fallopian tubes, to ensure that sperm ... Even rarer neoplasms include sarcoma, squamous cell carcinoma, yolk sac tumor, neuroendocrine carcinoma, paraganglioma, ... The lower part of the tube ends as a straight tube called the excretory duct which joins with the vas deferens of that side of ... An examination using cystoscopy, where a flexible tube is inserted in the urethra, may show disease of the vesicles because of ...
In females, this includes mammary glands, fallopian tubes, uterus, cervix, and vagina. In males, this includes the prostate, ... Neoplasms occurring in epithelial tissue such as the liver, gastrointestinal tract, and the pancreas have been linked to ...
... genital neoplasms, female MeSH C04.588.945.418.365 - fallopian tube neoplasms MeSH C04.588.945.418.948 - uterine neoplasms MeSH ... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ... femoral neoplasms MeSH C04.588.149.721 - skull neoplasms MeSH C04.588.149.721.450 - jaw neoplasms MeSH C04.588.149.721.450.583 ...
Palatnik A, Narayan R, Walters M (November 2012). "Extramedullary hematopoiesis involving uterus, fallopian tubes, and ovaries ... EMH in the lymph nodes is usually associated with underlying hematopoietic neoplasms. Myeloproliferative neoplasms (MPNs) tend ... para-nasal sinuses and numerous types of benign/malignant neoplasms. The most common sites of EMH associated with neoplastic ...
FIGO Committee on Gynecologic Oncology (April 2009). "Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and ... Trophoblastic neoplasms Seckl MJ, Sebire NJ, Berkowitz RS (August 2010). "Gestational trophoblastic disease". Lancet. 376 (9742 ... usually in the fallopian tube], or abortion) always indicate persistent GTD (very frequently due to choriocarcinoma or ... fallopian tube, ovary, and gestational trophoblastic neoplasia". International Journal of Gynaecology and Obstetrics. 105 (1): ...
... the fallopian tubes and other parts of the body that contains both carcinomatous (epithelial tissue) and sarcomatous ( ... Connective and soft tissue neoplasms). ...
It more rarely arises in the vagina and fallopian tubes as well as primary pelvic or peritoneal sites, such as the omentum, ... Malignant neoplasms arising in endometriosis: clinicopathological study of 14 cases. Clin Exp Obstet Gynecol. 2004;31(4):302-4 ...
It may originate from the ovary itself or more commonly from communicating nearby structures such as fallopian tubes or the ... They can develop further into a variety of other neoplasms, including choriocarcinoma, yolk sac tumor, and teratoma. They occur ... Serous carcinomas are thought to begin in the Fallopian tube. High grade serous carcinoma accounts for 75% of all epithelial ... Usually, this includes a unilateral salpingo-oophorectomy, removal of a single affected ovary and Fallopian tube. Fluid from ...
Prophylactic hysterectomy and salpingo-oophorectomy (removal of the uterus, Fallopian tubes, and ovaries to prevent cancer from ... and sebaceous neoplasms. Increased risk of prostate cancer and breast cancer has also been associated with Lynch syndrome, ...
Fallopian tube - The Fallopian tubes, also known as uterine tubes or salpinges (singular salpinx), are tubes that stretch from ... Papillary - In oncology, papillary refers to neoplasms with projections ("papillae", from Latin, 'nipple') that have ... The fertilized egg passes through the Fallopian tubes from the ovaries of female mammals to the uterus. The Fallopian tubes is ... In other animals, the equivalent of a Fallopian tube is an oviduct. Fellowship (medicine) - is the period of medical training, ...
... fallopian tube, spermatic cord, palate, and colon. The Maclean imaging classification system for renal angiomyolipomas is based ... Benign neoplasms, Urological neoplasia, Benign renal neoplasms). ...
However other organs such as ovaries, fallopian tubes, and the cervix are very frequently removed as part of the surgery. ... "Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms". PLOS ONE. 7 (11): e50058. Bibcode: ... Lymph nodes, ovaries, and fallopian tubes are also usually removed in this situation, such as in Wertheim's hysterectomy. Total ... It may also involve removal of the cervix, ovaries (oophorectomy), fallopian tubes (salpingectomy), and other surrounding ...
Delmore, James E. (2008). "Benign Neoplasms of the Vagina". GLOWM. doi:10.3843/GLOWM.10005. ISSN 1756-2228. Retrieved 11 March ... The fallopian tubes, also known as uterine tubes, oviducts or salpinges (SG: salpinx), are paired tubes in the human female ... Fallopian tube obstruction may be a cause of infertility or ectopic pregnancy. If a blocked fallopian tube has affected ... In other mammals the fallopian tube is called the oviduct which may also be used in reference to the fallopian tube in the ...
ClinicalTrials.gov: Fallopian Tube Neoplasms (National Institutes of Health) * ClinicalTrials.gov: Hereditary Breast and ... Fallopian tube cancer forms in the tissue lining a fallopian tube. The fallopian tubes are a pair of long, slender tubes on ... Risks of Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (National Cancer Institute) Also in Spanish ... Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (National Cancer Institute) Also in Spanish ...
fallopian tube cancer. *primary peritoneal cavity cancer. *Ovarian Neoplasms. *Peritoneal Neoplasms. *Fallopian Tube Neoplasms ... refractory or recurrent ovarian epithelial, primary peritoneal, or fallopian tube cancer.. II. Compare the tolerability of ... cancer, primary peritoneal cancer, or fallopian tube cancer Refractory or recurrent. disease after combination platinum and ...
... and neoplasms such as paratubal cysts, hydrosalpinx, or, rarely, fallopian tube cancer. Radiologic testing allows the ... 15, 16, 17] All include women with high-grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer at any ... fallopian tubes, and structures of the broad ligament. Most frequently, adnexal masses refer to ovarian masses or cysts; ... 9, 10] During adolescence, 50% of adnexal neoplasms are mature cystic teratomas (often known as dermoid cysts). Women with ...
... of cervix and fallopian tube (invasive). Primary carcinoma of the fallopian tube is a rare neoplasm, accounting for only 0.3- ... Simultaneous Squamous Cell Carcinoma of Cervix and Fallopian Tube; A Case Report. Publication Type : Journal Article ... HomePublicationsSimultaneous Squamous Cell Carcinoma of Cervix and Fallopian Tube; A Case Report ... "Simultaneous Squamous Cell Carcinoma of Cervix and Fallopian Tube; A Case Report", Indian Journal of Surgical Oncology, vol. 2 ...
Some investigators have demonstrated precursor cancerous lesions in the fallopian tube (tubal in-situ carcinoma [TIC]) and have ... Fallopian tube carcinomas were once believed to be rare. ... International Collaborative Ovarian Neoplasm trial 1: a ... encoded search term (Fallopian Tube Cancer Treatment Protocols) and Fallopian Tube Cancer Treatment Protocols What to Read Next ... Staging fallopian tube cancer involves the removal of both fallopian tubes and of the ovaries, uterus, cervix, infracolic ...
Dilated fallopian tubes appear as tubular fluid collections. A hydrosalpinx is generally anechoic, whereas a pyosalpinx may ... When ovarian neoplasms are encountered in girls of this age group, they fall into the germ cell, epithelial cell, and stromal/ ... A pyosalpinx (pus-filled fallopian tube) appears as a hyperechoic dilated mass in the adnexal region, often with low-level ... Initial inflammation of the endometrium may spread to the adnexa by the fallopian tubes, which connect with the endometrial ...
Pueperal Paratubal Cyst Torsion and Secondary Fallopian Tube Torsion Without Ovarian Involvement: A Case Report. Thanasa A, ... An Extremely Rare Gynecological Cancer Misdiagnosed Intraoperatively as Benign Ovarian Neoplasm: A Case Report. Thanasa E, ...
Use the menu to see other pages.READ MORE BELOWWhat is cancer staging?FIGO stages for ovarian, fallopian tube, and peritoneal ... of epithelial ovarian/fallopian tube neoplasms, which are abnormal growths of cells. Borderline tumors typically occur in ... Stage IB: The cancer is in both ovaries or fallopian tubes. No cancer is found on the surface of the ovary or fallopian tube or ... Stage IA: The cancer is only inside 1 ovary or fallopian tube. No cancer is found on the ovarian or fallopian tube surface or ...
Some investigators have demonstrated precursor cancerous lesions in the fallopian tube (tubal in-situ carcinoma [TIC]) and have ... Fallopian tube carcinomas were once believed to be rare. ... International Collaborative Ovarian Neoplasm trial 1: a ... encoded search term (Fallopian Tube Cancer Treatment Protocols) and Fallopian Tube Cancer Treatment Protocols What to Read Next ... Staging fallopian tube cancer involves the removal of both fallopian tubes and of the ovaries, uterus, cervix, infracolic ...
Breast neoplasms. Colorectal neoplasms. Fallopian tube neoplasms. Non-small-cell lung carcinoma. Ovarian neoplasms. Peritoneal ... Breast neoplasms Fallopian tube neoplasms. Non-small-cell lung carcinoma. Ovarian neoplasms. Peritoneal neoplasms. Renal cell ... Breast neoplasms Colorectal neoplasms. Fallopian tube neoplasms. Non-small-cell lung carcinoma. Ovarian neoplasms. Peritoneal ... Breast neoplasms. Colorectal neoplasms. Non-small-cell lung carcinoma. Ovarian neoplasms. Renal cell carcinoma 17 Aug 2022 ...
2120.0 Cancer, female genital tract Includes: Uterus Cervix Fallopian tube(s) Vagina Vulva Ovary(ies) Endometrium. 2125.0 ... 2150.0 Neoplasm of uncertain nature Excludes: Neoplasm, NOS Brain tumor (2130.0). ENDOCRINE, NUTRITIONAL, AND METABOLIC ... 4500.0 Tube insertion Includes: Chest tube Bad tube Catheter plugged. 4505.0 Cauterization, all sites. 4510.0 Urinary tract ... NEOPLASMS (2100-2199). Malignant neoplasms:. 2100.0 Cancer, gastrointestinal tract Includes: Esophagus Stomach Small intestine ...
Fallopian tube(s) Vagina Vulva Ovary(ies) Endometrium 2125.0 Cancer, urinary and male genital tract Includes: Bladder Kidney ... Benign Neoplasms 2140.0 Fibroids and other uterine neoplasms Includes: Myoma Leiomyomata Cervical polyp Nabothian cyst 2145.0 ... Tube insertion Includes: Chest tube Bad tube 4505.0 Cauterization, all sites 4510.0 Urinary tract instrumentation and ... Neoplasms Malignant Neoplasms 2100.0 Cancer, gastrointestinal tract Includes: Esophagus Stomach Small intestine Colon 2105.0 ...
ClinicalTrials.gov: Fallopian Tube Neoplasms By ACA , August 31, 2022. Need Caregiver Certification? Get that through the ...
Open the PDF for Neoplasms of the Fallopian Tube and Broad Ligament in another window ... fallopian tubes and uterine cervix . Int J Clin Exp Med 2013 ; 6 : 346 - 50 . 216. Nezhat CH... ...
Angiosarcoma of the ovary is rare but represents an aggressive type of malignant ovarian neoplasms. The purpose of this report ... The uterus and bilateral fallopian tubes were not remarkable. The omentum, pelvic and para-aortic lymph node specimens, and ... Angiosarcoma of the ovary is rare but represents an aggressive type of malignant ovarian neoplasms. The purpose of this report ... Angiosarcoma of the ovary is rare but represents an aggressive type of malignant ovarian neoplasms. To our knowledge, less than ...
C57 is a non-billable diagnosis code for malignant neoplasm of other and unsp female genital organs, use codes with a higher ... Fallopian tube cancer forms in the tissue lining a fallopian tube. The fallopian tubes are a pair of long, slender tubes on ... Malignant neoplasm of fallopian tube* C57.00 - Malignant neoplasm of unspecified fallopian tube* C57.01 - Malignant neoplasm of ... C57.02 - Malignant neoplasm of left fallopian tube* C57.1 - Malignant neoplasm of broad ligament* C57.10 - Malignant neoplasm ...
... fallopian tube, and Bartholins glands. Breast epithelium was variably positive, but typically stronger in the ducts than in ... Immunohistochemistry of Neoplasms. Staining for HE4 in 448 neoplasms is summarized in Table 2. Of ovarian tumors (Figure 2), ... All salivary gland neoplasms demonstrated some reactivity. Prominent staining was identified in the epithelium of Warthins ... Staining for HE4 in non-ovarian neoplasms is summarized in Figure 4. Nearly 90% of endometrial carcinomas, endometrioid type, ...
Epithelial Neoplasms of Ovary, Fallopian Tube and Pelvic Peritoneum - C. Blake Gilks, MD Section: 2 Presentations 1 Document 1 ... Epithelial Neoplasms of the Uterine Corpus - Robert A. Soslow, MD Section: 2 Presentations 1 Document 1 Certificate 1 Survey ... Mesenchymal Neoplasms of the Uterine Corpus - Esther Oliva, MD Section: 2 Presentations 1 Document 1 Certificate 1 Survey ... Germ Cell and Sex Cord Stromal Neoplasms of The Ovary - Joseph T. Rabban III, MD, MPH Section: 1 Presentation 1 Document 1 ...
... the offspring of DES-exposed mothers also had functional and anatomical abnormalities of the uterus and fallopian tubes. ... In 1971, DES was linked with a rare gynecologic neoplasm in female offspring of DES-exposed pregnancies [76]. Subsequent ...
Fallopian Tube Neoplasms; Peritoneal Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, ... Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, ... Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical ... Peritoneal Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, ...
Ovarian Neoplasms 60% * Uterine Cervical Neoplasms 59% * Pregnancy 58% * Fallopian Tubes 56% ...
Rectal neoplasms. D012004. 2. 1. -. -. -. 3. Fallopian tube neoplasms. D005185. 3. 1. -. -. -. 3. ... Ovarian neoplasms. D010051. EFO_0003893. C56. 3. -. -. -. -. 3. Stomach neoplasms. D013274. EFO_0003897. C16. 3. -. -. -. -. 3 ... Breast neoplasms. D001943. EFO_0003869. C50. 7. 2. -. -. -. 8. Ulcerative colitis. D003093. EFO_0000729. K51. 1. 3. -. -. 1. 5 ... Liver neoplasms. D008113. EFO_1001513. C22.0. 2. -. -. -. -. 2. Necrotizing enterocolitis. D020345. EFO_0003928. K55.3. 1. -. - ...
An adenocarcinoma that arises from the fallopian tube. Histologic subtypes include clear cell, endometrioid, serous, and ... Neoplasm*Epithelial neoplasm*Carcinoma*Adenocarcinoma*Fallopian tube adenocarcinoma*Fallopian tube clear cell adenocarcinoma* ... adenocarcinoma of fallopian tube; Adenocarcinoma of the Fallopian Tube; adenocarcinoma of the fallopian tube; Fallopian Tube ... Fallopian tube serous adenocarcinoma*Fallopian Tube High Grade Serous Adenocarcinoma*Metastatic Fallopian Tube High Grade ...
Ovarian Neoplasms 100% * Fallopian Tube Neoplasms 59% * Epithelium 55% * Fallopian Tubes 29% ...
Neoplasms Medicine & Life Sciences 47% * Fallopian Tube Neoplasms Medicine & Life Sciences 33% ...
Fallopian tube high-grade serous adenocarcinoma that is resistant to treatment. ... Epithelial neoplasm*Carcinoma*Adenocarcinoma*Fallopian tube adenocarcinoma*Fallopian tube serous adenocarcinoma*Fallopian Tube ... Refractory Fallopian Tube High Grade Serous Adenocarcinoma Refractory Fallopian Tube High Grade Serous Adenocarcinoma. ... Refractory Fallopian Tube High-Grade Serous Adenocarcinoma; Refractory High Grade Fallopian Tube Serous Adenocarcinoma. ...
Breast Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma ... Peritoneal Neoplasms; Fallopian Tube Neoplasms; Lymphoma; Gallbladder Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non- ... Fallopian Tube Neoplasms; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lung Neoplasms; Peritoneal Neoplasms; Colorectal ... Colonic Neoplasms; Pancreatic Neoplasms; Neoplasms; Rectal Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms. Details ...
  • However, investigators have demonstrated precursor cancerous lesions in the fallopian tube (tubal in-situ carcinoma [TIC]) and have provided evolutionary evidence that many advanced serous ovarian cancers originate in the fallopian tubes. (medscape.com)
  • We report a case of simultaneous Squamous cell carcinoma(SCC) of cervix and fallopian tube (invasive). (amrita.edu)
  • Primary carcinoma of the fallopian tube is a rare neoplasm, accounting for only 0.3-1.1% of all gynecological malignancies [1]. (amrita.edu)
  • Adeno-carcinoma is the predominant type and is included in the criteria established by Finn and Javert for diagnosis of primary carcinoma of fallopian tube [2]. (amrita.edu)
  • Primary fallopian tube carcinoma: treatment and spread pattern. (nih.gov)
  • Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. (nih.gov)
  • Serous adenocarcinoma of the fallopian tube, associated with verrucous carcinoma of the uterine cervix: a case report of synchronic rare gynecological tumors. (nih.gov)
  • Port-site metastases after laparoscopy were reported for one patient each with a diagnosis of fallopian tube carcinoma and vaginal carcinoma. (houstonmethodist.org)
  • Fallopian tube carcinoma is a rare gynecological malignancy with low accuracy detection preoperatively. (biomedcentral.com)
  • After pathologic and immunohistochemistry tests, the diagnosis of fallopian tube carcinoma with peritoneal dissemination was made. (biomedcentral.com)
  • This case is very unique in the way that a small primary fallopian tube carcinoma was able to disseminate to the upper abdominal quadrant with little pelvic dissemination. (biomedcentral.com)
  • Although a rare occurrence, we should not forget fallopian tube carcinoma in the differential diagnosis of peritoneal carcinomatosis, even in the absence of Latzke's triad. (biomedcentral.com)
  • His biological study spans a wide range of topics, including Ovarian carcinoma, Ovarian tumor, Ovarian cancer and Fallopian tube. (research.com)
  • He combines subjects such as SMARCA4, Ovarian carcinoma, Ovarian cancer, Fallopian tube and Transitional Cell with his study of Ovary. (research.com)
  • The response rate to checkpoint inhibitors for women with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum (HGSC) is modest, and development of predictive biomarkers is needed. (lu.se)
  • Using integrated molecular genomics, researchers confirm and extend prior research showing that high-grade serous carcinomas (HGSCs) in the pelvis are preceded by serous tubal intraepithelial carcinoma (STIC) lesions occurring in the fallopian tubes. (medscape.com)
  • An egg cell is transported from an ovary to a fallopian tube where it may be fertilized in the ampulla of the tube. (wikipedia.org)
  • An ovary is not directly connected to its adjacent fallopian tube. (wikipedia.org)
  • An oocyte is released from the ovary into the peritoneal cavity and the cilia of the fimbriae sweep it into the fallopian tube. (wikipedia.org)
  • The cancer is only inside 1 ovary or fallopian tube. (cancer.net)
  • No cancer is found on the surface of the ovary or fallopian tube or in the peritoneal fluid or washings. (cancer.net)
  • The tumor wall is ruptured before surgery, or there is cancer on the surface of the ovary or fallopian tube. (cancer.net)
  • Angiosarcoma of the ovary is rare but represents an aggressive type of malignant ovarian neoplasms. (hindawi.com)
  • The study included 982 patients with benign, borderline, and malignant ovarian neoplasms and normal ovary. (biomedcentral.com)
  • Normal ovary with 7 twists of fallopian tube seen. (jpgo.org)
  • His research in Ovary tackles topics such as Fallopian tube which are related to areas like Peritoneal cancer. (research.com)
  • My appendix, right ovary, and right fallopian tube were removed. (pmppals.net)
  • These cancers refer to the origin of neoplastic diseases affecting the organs of the female reproductive system, and may originate in the breasts, cervix, uterine body, endometrium, ovary, vulva, vagina and fallopian tube. (bvsalud.org)
  • Sp17 expression was limited in other benign and non-epithelial malignant neoplasms. (biomedcentral.com)
  • Sp17 is highly expressed in benign, borderline, and low grade malignant serous ovarian neoplasms and can be quantified in serum. (biomedcentral.com)
  • At present, serum CA-125 is the most extensively used biomarker to preoperatively discriminate between benign and malignant ovarian neoplasms, detect recurrence, and monitor response to treatment. (biomedcentral.com)
  • Thus, type I (low-grade serous G1, low-grade endometrioid G1/G2, mucinous or clear cell) tumors are associated with corresponding benign ovarian cystic neoplasms, often developing through an intermediate borderline step and have a better prognosis. (spandidos-publications.com)
  • These neoplasms can be benign or malignant. (lookformedical.com)
  • Currently, she added, "in a lot of practices, when we are doing a hysterectomy for benign indications and leaving the ovaries, we are taking out the fallopian tubes and that is based on the original histopathology data that shows that at least 50% of serous cancers have some sort of STIC lesion associated with them. (medscape.com)
  • The fallopian tubes, also known as uterine tubes, oviducts or salpinges (SG: salpinx), are paired tubes in the human female body that stretch from the uterus to the ovaries. (wikipedia.org)
  • The tubes extend to near the ovaries where they open into the abdomen at the distal tubal openings. (wikipedia.org)
  • Historically, postmenopausal women with clinically detectable ovaries were thought to be at great risk of having a malignant neoplasm. (medscape.com)
  • Staging fallopian tube cancer involves the removal of both fallopian tubes and of the ovaries, uterus, cervix, infracolic omentum, and retroperitoneal lymph nodes, in addition to peritoneal washings and peritoneal biopsies. (medscape.com)
  • The cancer is only in the ovaries or fallopian tubes. (cancer.net)
  • The cancer involves 1 or both of the ovaries or fallopian tubes and has spread below the pelvis, or it is peritoneal cancer. (cancer.net)
  • The cancer has spread to the uterus and/or fallopian tubes and/or the ovaries. (cancer.net)
  • Mounting evidence suggests that most, if not all, serous ovarian cancers start in the fallopian tubes, not in the ovaries. (medscape.com)
  • In very select situations - women who are at very high risk for ovarian cancer - our recommendation at the appropriate age is to have the ovaries and fallopian tubes removed. (medscape.com)
  • This leads us to believe that these ovarian cancers all originate in the fallopian tubes," said Dr Levine. (medscape.com)
  • During surgery a small change of color and consistency of her left fallopian tube was noted and unilateral adnexectomy was performed. (biomedcentral.com)
  • The fallopian tubes are lined with simple columnar epithelium with hairlike extensions called cilia which together with peristaltic contractions from the muscular layer, move the fertilized egg (zygote) along the tube. (wikipedia.org)
  • By definition, serous tumors are characterized by a proliferation of epithelium resembling that lining the fallopian tubes. (medscape.com)
  • EOC can include cells of origin from both the ovarian surface epithelium and the fallopian tube ( 2 ). (spandidos-publications.com)
  • But recent data suggest that HGSC of the pelvis likely originates from the epithelium of the distal portion of the fallopian tube. (medscape.com)
  • HGSCs had molecular profiles more similar to normal fallopian tube epithelium than to ovarian surface epithelium or peritoneum. (medscape.com)
  • Splenic metastasis of a fallopian tube adenocarcinoma. (nih.gov)
  • Anterior mediastinal metastasis of primary fallopian tube adenocarcinoma: a case report. (nih.gov)
  • Fallopian tube adenocarcinoma: common extraperitoneal recurrence. (nih.gov)
  • Epithelial cystic tumors account for about 60% of all true ovarian neoplasms. (medscape.com)
  • Mucinous epithelial tumors account for approximately 10-15% of all epithelial ovarian neoplasms. (medscape.com)
  • Nonepithelial malignant neoplasms sometimes arise in mucinous tumors, typically as mural nodules. (hindawi.com)
  • Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. (lookformedical.com)
  • They are very different from high-grade cancers and represent about 10% to 15% of epithelial ovarian/fallopian tube neoplasms, which are abnormal growths of cells. (cancer.net)
  • A number of tubal pathologies cause damage to the cilia of the tube which can impede movement of the sperm or egg. (wikipedia.org)
  • Each fallopian tube leaves the uterus at an opening at the uterine horns known as the proximal tubal opening or proximal ostium. (wikipedia.org)
  • Each tube is composed of four parts: from inside the proximal tubal opening the intramural or interstitial part, that links to the narrow isthmus, the isthmus connects to the larger ampulla, which connects with the infundibulum and its associated fimbriae that opens into the peritoneal cavity from the distal tubal opening. (wikipedia.org)
  • There are also various physiological factors which can cause torsion which include hyper motility of the fallopian tube, or tubal spasm or increased peristalsis. (jpgo.org)
  • Other congenital pathologies have also been mentioned which include long tubal size, excessive spiral nature of the tube, incomplete mesosalpinx, and large cysts of morgagni. (jpgo.org)
  • C57 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of other and unspecified female genital organs. (icdlist.com)
  • Right sided tube was dilated with mild hydrosalpinx with isolated 7 twists of the fallopian tube. (jpgo.org)
  • The dilated fallopian tube can contain simple fluid (hydrosalpinx), blood (hematosalpinx), or pus (pyosalpinx) and can mimic ovarian cysts and cystic neoplasms. (stuffmakesmehappy.com)
  • Patients who did not undergo full colonoscopy preoperatively should undergo colonoscopy within 3-6 months postoperatively to exclude other synchronous colorectal neoplasms and 1 year thereafter. (health.am)
  • Each tube has two openings a proximal opening nearest and opening to the uterus, and a distal opening furthest and opening to the abdomen. (wikipedia.org)
  • The intramural part or interstitial part of the fallopian tube lies in the myometrium, the muscular wall of the uterus. (wikipedia.org)
  • This is the narrowest part of the tube that crosses the uterus wall to connect with the isthmus. (wikipedia.org)
  • The narrow isthmus links the tube to the uterus, and connects to the ampulla. (wikipedia.org)
  • The fallopian tubes are a pair of long, slender tubes on each side of the uterus. (medlineplus.gov)
  • His research integrates issues of Neoplasm staging and Peritoneal cancer in his study of Fallopian tube. (research.com)
  • The fallopian tubes are held in place by the mesosalpinx, a part of the broad ligament mesentery that wraps around the tubes. (wikipedia.org)
  • The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament). (harvard.edu)
  • Because the fallopian tubes are connected to the cervix and the vagina, we can get very close to them, and proteins and biomarkers can flow between these structures quite easily," Dr Levine told Medscape Medical News . (medscape.com)
  • [ 1 , 2 ] Currently, both early-stage and advanced-stage fallopian tube cancers are treated in much the same way as ovarian cancers-that is, with surgery followed by chemotherapy. (medscape.com)
  • Surgery is the initial therapy for stage I-IV fallopian tube cancers. (medscape.com)
  • Only a small percentage of women with epithelial fallopian tube cancers are treated with surgery alone. (medscape.com)
  • no randomized trials have specifically addressed fallopian tube cancers. (medscape.com)
  • Accordingly, the chemotherapy used to treat primary fallopian tube cancers is based on the standard management of ovarian cancers. (medscape.com)
  • Doctors also describe ovarian/fallopian tube cancers by their grade. (cancer.net)
  • In the group of neoplasms, female cancers are responsible for more than half of cancer deaths among women in Brazil. (bvsalud.org)
  • This whole paradigm shift that ovarian cancers start in the fallopian tubes is already changing practice," Dr Levine told Medscape Medical News . (medscape.com)
  • This study helps us have a greater understanding that all serous cancers and invasive cancers look very similar whether there is a STIC in the fallopian tube or not. (medscape.com)
  • We already believe that the tube is where serous ovarian cancers start. (medscape.com)
  • Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. (lookformedical.com)
  • Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. (lookformedical.com)
  • Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. (lookformedical.com)
  • In fact, most patients with stage I disease are treated with adjuvant chemotherapy because of the luminal structure of the organ and the risk of shedding cells out of the tubes and into the abdominal cavity. (medscape.com)
  • Biopsies confirmed the tumor was a rare, stage IV appendix cancer called Low-Grade Appendiceal Mucinous Neoplasm (LAMN). (pmppals.net)
  • Fallopian tube carcinomas were once believed to be rare. (medscape.com)
  • 18 With the exception of the ovarian neoplasms, the same carcinomas analyzed for gene expression were also examined for HE4 by immunohistochemistry on tissue microarrays (see below). (nature.com)
  • Almost a third of cases of infertility are caused by fallopian tube pathologies. (wikipedia.org)
  • The data support the rationale to focus on the distal fallopian tube when surgical or medical approaches to prevent HGSC are being considered, the researchers say. (medscape.com)
  • Symptoms include profuse vaginal discharge, abnormal vaginal bleeding, pelvic or abdominal pain (usually colicky pain due to tube distension) and a pelvic and/or abdominal mass can be palpable [ 5 ]. (biomedcentral.com)
  • Isolated Fallopian tube torsion is a rare gynecological cause of chronic or acute lower abdominal pain. (jpgo.org)
  • No cancer is found on the ovarian or fallopian tube surface or in the abdomen. (cancer.net)
  • Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients. (nih.gov)
  • For ovarian/fallopian tube cancer, the staging system developed by the International Federation of Obstetrics and Gynecology (Federation Internationale de Gynecologie et d'Obstetrique, or FIGO) is used. (cancer.net)
  • A failure to intraoperatively recognize this malignant neoplasm may result in incomplete surgical staging procedure or inappropriate clinical management. (hindawi.com)
  • The functional and clinical significance of the identified mutations was examined using a combination of population-based whole genome sequencing, targeted deep sequencing, multi-center analysis of protein expression, loss of function experiments in an in-vivo reporter assay and mammalian models, and gain of function experiments in primary cultured fallopian tube epithelial (FTE) cells. (birmingham.ac.uk)
  • Now that we believe that ovarian cancer comes from the fallopian tubes, the question is, could something like a Pap smear detect DNA mutations or protein fragments? (medscape.com)
  • The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. (lookformedical.com)
  • STIC lesions, the putative precursor to HGSC, have been found in the fallopian tube and in about half of advanced-stage HGSCs. (medscape.com)
  • Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. (omeka.net)
  • Fallopian tube cancer forms in the tissue lining a fallopian tube. (medlineplus.gov)